XML 76 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Compensation [Abstract]  
Schedule of Option Pricing Model and Adopted Fair Value Per Share The Group uses binomial option pricing model and adopted fair value per share of ordinary share to determine fair value of the share-based awards. The estimated fair value of each option or each restricted share granted is estimated on the date of grant using the binomial option-pricing model or fair value per share of ordinary share with the following assumptions:
   For the years ended December 31, 
Options*  2021   2022   2023 
Fair value per share (US$) 

3.81-5.58

  
*
  

6.33-6.37

 
Discount rate (after tax)  16.50%-18.00%   *   Not applicable 
Risk-free interest rate  1.66%  *   3.88% 
Expected volatility  42.05%-54.06%   *   64.2% 
Contractual term (in years)  10   *   10 
Discount for lack of marketability (“DLOM”)  7.00%-12.00%   *   Not applicable 
*There were no grants for options for the year ended December 31, 2022.

 

   For the years ended December 31,
Restricted shares  2021   2022  2023 (prior to the Business Combination)
Fair value per share (US$)  3.81-5.58   3.81-4.08 

4.90-5.45

Discount rate (after tax)  16.50%-18.00%   16.5%

15.0%-16.0%

Discount for lack of marketability (“DLOM”)  7.00%-12.00%   10% 5%-10%
Schedule of Stock Options Activities The following table presents a summary of the Company’s stock options activities for the years ended December 31, 2021, 2022 and 2023.
   Number of Options Outstanding*   Weighted
Average exercise
   Weighted average
remaining
   Aggregated 
   Employees   Consultant   Total   price   contractual life   intrinsic value 
   (in thousands)   (in thousands)   (in thousands)   US$   (in years)   RMB in thousands 
Outstanding at January 1, 2021   8,562    331    8,893    2.0163               6.76    65,574 
Granted   547    
-
    547    8.0748    
-
    
-
 
Forfeited   (1,433)   
-
    (1,433)   5.3355    
-
    
-
 
Outstanding at December 31, 2021   7,676    331    8,007    1.8362    5.69    65,574 
Exercisable as of December 31, 2021   7,676    331    8,007    1.8362    5.69    65,574 
                               
Outstanding at January 1, 2022   7,676    331    8,007    1.8362    5.69    65,574 
   Forfeited   (58)   
-
    (58)   8.0885    
-
    
-
 
Outstanding at December 31, 2022   7,618    331    7,949    1.7905    4.67    65,572 
Exercisable as of December 31, 2022   7,618    331    7,949    1.7905    4.67    65,572 
                               
Outstanding at January 1, 2023   7,618    331    7,949    1.7905    4.67    65,572 
Replacement   (7,545)   (331)   (7,876)   1.3119    
-
    
-
 
Granted   528    
-
    528    0.1000    
-
    
-
 
Forfeited   (28)   
-
    (28)   8.1954    
-
    
-
 
Outstanding at December 31, 2023   573    
-
    573    0.6675    9.73    23,775 
Exercisable as of December 31, 2023   295    
-
    295    1.1978    9.48    11,367 
*Shares outstanding for all periods reflect the adjustment for Reverse Recapitalization (Note 3).
Schedule of Restricted Share Activities The following table sets forth the summary of restricted share activities for the years ended December 31, 2021, 2022 and 2023:
   Number of Restricted
Shares Granted*
  

Weighted-Average

Grant Date

Fair Value

 
   (in thousands)   (US$) 
Unvested as of January 1, 2021   546    4.3444 
Awarded   997    5.0346 
Vested   (340)   4.5173 
Forfeited   (3)   4.6634 
Outstanding at December 31, 2021   1,200    4.8681 
Unvested as of January 1, 2022   1,200    4.8681 
Awarded   124    3.9252 
Vested   (498)   4.7458 
Forfeited   (40)   3.9504 
Outstanding at December 31, 2022   786    4.8435 
Unvested as of January 1, 2023   786    4.8435 
Replacement   7,876    4.9821 
Awarded   703    6.4017 
Vested   (8,938)   5.0743 
Forfeited   (97)   5.5168 
Outstanding at December 31, 2023   330    5.0233 
*Shares outstanding for all periods reflect the adjustment for Reverse Recapitalization (Note 3).